3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Zollinger-Ellison Syndrome
1
Vomiting
1
Precancerous Conditions
1
Nausea
1
Esophageal Neoplasms
1
Breast Neoplasms
1
Barrett Esophagus
1
Interventions
Dexamethasone
23
Ondansetron
12
Palonosetron
11
Aprepitant
9
Granisetron
7
Olanzapine
5
ramosetron
3
netupitant, palosentron drug combination
3
casopitant
3
Radiotherapy
3
fosaprepitant
2
Thalidomide
2
Prochlorperazine
2
Electroacupuncture
2
Dronabinol
2
Analgesia
2
Acupressure
2
sinomenine
1
netupitant
1
lerisetron
1
dolasetron
1
dexamethasone acetate
1
Tropisetron
1
Therapeutics
1
Taxes
1
Tablets
1
Surveys and Questionnaires
1
Sugars
1
Metoclopramide
1
Hygiene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Vomiting
×
Esomeprazole
×
Clear all
NCT00206440
2018-12-06
NEXIUM
Baylor Breast Care Center
Phase 3
Terminated
43 enrolled
5 charts